News for Healthier Living

AACR: New CAR T Cell Therapy Benefits Patients with Advanced Thyroid Cancers

* Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors * One patient experienced a complete response, and one patient had a partial response * This type of cancer has limited treatment options, and most patients have a poor prognosis of six months or less * AIC100 is a CAR T cell therapy that targets the ICAM-1 protein on tumor cells

April 29, 2025


April 29 2025

April 28 2025

April 27 2025

April 26 2025

April 25 2025

April 24 2025

April 23 2025

April 22 2025

April 21 2025

April 19 2025

April 18 2025

April 17 2025

April 16 2025

April 15 2025